Changing the Practice of Medicine
Popular
María-Victoria Mateos, MD, PhD
Luciano Costa, M.D., Ph.D.
- MinuteCE®
Unmet Need: Second-Line Outcomes Remain Poor for NSCLC and Pancreatic Cancer
0.75 program creditsKathryn Arbour
Eileen M. O'Reilly, MD
Eileen M. O'Reilly, MD
Kathryn Arbour
- CME/CE
Breaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
0.25 creditsMaría-Victoria Mateos, MD, PhD
David Rubin, MD
Kimberly D. Orleck, PA-C
David Rubin, MD
Jennifer Geremia, PA-C
David Rubin, MD
Brooke Hodnick, PA-C, MPAS
Kimberly D. Orleck, PA-C
Jennifer Geremia, PA-C
CME/CE
Kathryn Arbour
Eileen M. O'Reilly, MD
David Rubin, MD
Brooke Hodnick, PA-C, MPAS
David Rubin, MD
Kimberly D. Orleck, PA-C
Pushpa Narayanaswami, MD, FAAN
A.J. Gelderblom, MD, PhD
- MinuteCE®
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
1.00 credit 10 episodesA.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
Clinical Practice
Kimberly D. Orleck, PA-C
Brooke Hodnick, PA-C, MPAS
Linda Stein Gold, MD
Bruce Strober, MD, PhD
Michiel van de Sande, MD, PhD
- MinuteCE®
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
1.00 program creditA.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
A.J. Gelderblom, MD, PhD
Programs
- CME/CE
Advancing Bispecific Antibodies Upstream in the Treatment Paradigm of Multiple Myeloma
0.25 creditsMaría-Victoria Mateos, MD, PhD
Kevin J Harrington, PhD, FRCP, FRCR, FRSB
Christophe Le Tourneau, MD, PhD
A.J. Gelderblom, MD, PhD
- MinuteCE®
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
1.00 program creditA.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Tina Q. Tan, MD
Yvonne Maldonado, MD
Tina Q. Tan, MD